Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Eli Lilly and Company (“Eli Lilly”) (NYSE: LLY) breached their fiduciary duties to Eli Lilly and its shareholders.

CLICK HERE TO LEARN MORE

Scott+Scott is investigating whether members of Eli Lilly’s board of directors or senior management failed to manage Eli Lilly in an acceptable manner, in breach of their fiduciary duties to Eli Lilly, and whether Eli Lilly and its shareholders have suffered damages as a result.

On December 31, 2025, the Indiana Attorney General’s office filed a lawsuit against Eli Lilly for allegedly participating in a scheme to artificially inflate the price of insulin.

What You Can Do – CLICK HERE FOR YOUR OPTIONS AS A SHAREHOLDER

If you own shares of Eli Lilly, you may have legal claims against Eli Lilly’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at [phone] or [e-mail].

About Us

Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations.

With 150 attorneys plus supporting staff in eight offices in the United States as well as one office in Canada and three in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief.

Our attorneys have been recognized across legal publications, including by Lawdragon for being among the 500 Top Financial Lawyers and the 500 Leading Global Antitrust & Competition Lawyers. In addition, we have received top rankings by WWL: Commercial Litigation, Legal 500 in Antitrust as well as Securities Litigation, Chambers, and Best Lawyers. Our attorneys have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States.

To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com.

Attorney Advertising

View source version on businesswire.com: https://www.businesswire.com/news/home/20260122650726/en/

The Eli Lilly Stock at the time of publication of the news with a raise of 0,00 % to 922,9EUR on Tradegate stock exchange (22. Januar 2026, 16:00 Uhr).